Anti-Immunoglobulin E Treatment with Omalizumab in Allergic Diseases an Update on Anti-Inflammatory Activity and Clinical Efficacy

Publisher： Bentham Science Publishers

E-ISSN： 1875-614x|7|1|27-31

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.7, Iss.1, 2008-03, pp. : 27-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug

By Agrawal D.K.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 3, 2001-03 ,pp. : 547-560

Informa Healthcare

Access to resources Recommend Favorite

Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-09 ,pp. : 227-229

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Immunoglobulin E Therapy for Asthma

By Owen C.E.

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 5, 2002-10 ,pp. : 417-424

Academic Press

Access to resources Recommend Favorite

Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma

By Chung K Fan

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases?

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 1, 2017-12 ,pp. : 36-50

Bentham Science Publishers

Access to resources Recommend Favorite